Taiwan FDA registration c234b0fa4a31c7ddc53911a906fcbc52
TERC/Chr3cen probe (unsterilized)
TW: “博錸”TERC/Chr3cen探針 (未滅菌)
Taiwan·Risk Class 1·PLEXBIO CO., LTD.·Registered Jan 26, 2015 – Jan 26, 2020CancelledRegistration details
- Analysis ID
- c234b0fa4a31c7ddc53911a906fcbc52
Company information
- Manufacturer
- PLEXBIO CO., LTD.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- PLEXBIO CO., LTD.
Product details
- Intended Use
- Limited to the first level identification range of immunopathological histochemical reagents and kits (B.1860) of the Measures for the Administration of Medical Devices.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.1860 Immunopathological histochemistry reagents and kits
- Import Information
- Domestic
Dates and status
- Registration Date
- Jan 26, 2015
- Expiry Date
- Jan 26, 2020
- Cancellation Date
- Dec 05, 2017
Cancellation information
- Status
- Logged out
- Reason
- 自請註銷
About this record
Access comprehensive regulatory information for TERC/Chr3cen probe (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number c234b0fa4a31c7ddc53911a906fcbc52 and manufactured by PLEXBIO CO., LTD.. The authorized representative in Taiwan is PLEXBIO CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices